Community Healthcare Trust (CHCT) Financials

$17.03 +0.17 (+1.01%)

Closing price 05/2/2025 03:59 PM Eastern

Extended Trading

$17.14 +0.11 (+0.64%)

As of 05/2/2025 05:16 PM Eastern

Annual Income Statements for Community Healthcare Trust

This table shows Community Healthcare Trust's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	22	7.71	-3.18
Consolidated Net Income / (Loss)	22	7.71	-3.18
Net Income / (Loss) Continuing Operations	22	7.71	-3.18
Total Pre-Tax Income	22	8.02	-3.18
Total Revenue	86	96	93
Net Interest Income / (Expense)	-12	-17	-23
Total Interest Income	0.07	0.81	0.53
Other Interest Income	0.07	0.81	0.53
Total Interest Expense	12	18	24
Long-Term Debt Interest Expense	12	18	24
Total Non-Interest Income	98	113	116
Other Service Charges	3.58	4.16	1.22
Other Non-Interest Income	94	109	115
Provision for Credit Losses	0.00	0.00	11
Total Non-Interest Expense	64	88	85
Property & Liability Insurance Claims	17	21	23
Other Operating Expenses	15	27	19
Depreciation Expense	32	40	43
Impairment Charge	0.00	0.10	0.12
Income Tax Expense	0.04	0.31	0.00
Basic Earnings per Share	$0.81	$0.20	($0.23)
Weighted Average Basic Shares Outstanding	23.63M	25.20M	26.53M
Diluted Earnings per Share	$0.81	$0.20	($0.23)
Weighted Average Diluted Shares Outstanding	23.63M	25.20M	26.53M
Weighted Average Basic & Diluted Shares Outstanding	26.02M	27.68M	28.34M
Cash Dividends to Common per Share	$1.77	$1.81	$1.85

This table shows Community Healthcare Trust's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	5.67	5.24	-6.92	6.58	3.49	4.57	3.67	-10	1.75	1.83
Consolidated Net Income / (Loss)	5.67	5.24	-6.92	6.58	3.49	4.57	3.67	-10	1.75	1.83
Net Income / (Loss) Continuing Operations	5.67	5.22	-6.92	6.58	3.49	4.57	3.67	-10	1.75	1.83
Total Pre-Tax Income	5.69	2.63	-6.89	6.63	3.82	4.47	3.67	-10	1.74	1.84
Total Revenue	22	22	23	24	24	24	24	28	30	11
Net Interest Income / (Expense)	-3.02	-3.46	-3.97	-3.39	-4.64	-4.98	-5.06	0.31	0.21	-19
Total Interest Income	0.01	0.00	0.03	0.75	0.00	0.04	0.00	0.31	0.21	0.02
Total Interest Expense	3.03	3.46	3.99	4.14	4.64	5.02	5.06	0.00	0.00	19
Total Non-Interest Income	25	25	27	28	29	29	29	28	30	29
Other Service Charges	0.89	0.96	1.05	1.05	1.05	1.02	0.99	-0.39	0.30	0.32
Other Non-Interest Income	24	24	26	27	28	28	28	28	29	29
Total Non-Interest Expense	16	17	30	18	20	20	21	21	22	21
Property & Liability Insurance Claims	4.33	4.16	4.87	4.79	5.46	5.60	5.79	5.57	5.99	5.49
Other Operating Expenses	3.76	4.15	16	3.79	3.62	3.73	4.55	4.76	4.94	4.81
Depreciation Expense	8.00	8.32	9.02	9.22	11	10	10	11	11	11
Basic Earnings per Share	$0.21	$0.18	($0.32)	$0.24	$0.11	$0.17	$0.11	($0.42)	$0.04	$0.04
Weighted Average Basic Shares Outstanding	23.59M	23.63M	24.23M	25.07M	25.51M	25.20M	26.30M	26.48M	26.66M	26.53M
Diluted Earnings per Share	$0.21	$0.18	($0.32)	$0.24	$0.11	$0.17	$0.11	($0.42)	$0.04	$0.04
Weighted Average Diluted Shares Outstanding	23.59M	23.63M	24.23M	25.07M	25.51M	25.20M	26.30M	26.48M	26.66M	26.53M
Weighted Average Basic & Diluted Shares Outstanding	25.30M	26.02M	26.30M	26.56M	27.26M	27.68M	27.70M	28.06M	28.24M	28.34M

This table details how cash moves in and out of Community Healthcare Trust's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	9.20	-7.44	-0.25
Net Cash From Operating Activities	60	61	59
Net Cash From Continuing Operating Activities	60	61	59
Net Income / (Loss) Continuing Operations	22	7.71	-3.18
Consolidated Net Income / (Loss)	22	7.71	-3.18
Provision For Loan Losses	0.00	0.00	11
Depreciation Expense	32	40	43
Amortization Expense	0.85	13	0.93
Non-Cash Adjustments to Reconcile Net Income	6.01	4.82	8.17
Changes in Operating Assets and Liabilities, net	-0.94	-3.39	-0.81
Net Cash From Investing Activities	-114	-114	-93
Net Cash From Continuing Investing Activities	-113	-114	-92
Purchase of Property, Leasehold Improvements and Equipment	-10	-19	-25
Purchase of Investment Securities	-106	-101	-75
Sale and/or Maturity of Investments	3.00	6.19	7.42
Other Investing Activities, net	0.67	-	0.22
Net Cash From Financing Activities	63	45	34
Net Cash From Continuing Financing Activities	63	45	34
Issuance of Debt	150	50	162
Issuance of Common Equity	21	44	7.49
Repayment of Debt	-63	-0.13	-83
Payment of Dividends	-44	-48	-52
Other Financing Activities, Net	-0.39	-1.19	-1.01
Cash Interest Paid	11	18	23

This table details how cash moves in and out of Community Healthcare Trust's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	0.98	8.73	-7.44	-0.95	1.26	-0.30	0.31	-4.21	2.10	1.55
Net Cash From Operating Activities	15	15	13	17	18	14	13	17	14	16
Net Cash From Continuing Operating Activities	15	15	13	17	18	14	13	17	14	16
Net Income / (Loss) Continuing Operations	5.67	5.24	-6.92	6.58	3.49	4.57	3.67	-10	1.75	1.83
Consolidated Net Income / (Loss)	5.67	5.24	-6.92	6.58	3.49	4.57	3.67	-10	1.75	1.83
Depreciation Expense	8.00	8.32	9.02	9.22	11	10	10	11	11	11
Amortization Expense	0.21	0.23	12	0.24	0.05	0.19	0.22	0.17	0.25	0.29
Non-Cash Adjustments to Reconcile Net Income	1.63	1.81	1.67	0.22	1.78	1.16	1.67	2.81	1.81	1.87
Changes in Operating Assets and Liabilities, net	-0.16	-0.18	-3.13	0.42	1.19	-1.87	-3.17	2.38	-0.90	0.87
Net Cash From Investing Activities	-22	-58	-29	-16	-55	-14	-39	-30	-14	-9.49
Net Cash From Continuing Investing Activities	-22	-57	-29	-16	-55	-14	-39	-30	-14	-9.43
Purchase of Property, Leasehold Improvements and Equipment	-3.05	-3.68	-4.14	-3.75	-3.58	-7.52	-5.11	-7.19	-7.19	-5.16
Purchase of Investment Securities	-20	-55	-25	-17	-52	-6.90	-34	-24	-8.91	-8.42
Sale and/or Maturity of Investments	0.75	0.75	0.75	3.78	0.79	0.87	0.87	0.75	1.72	4.09
Other Investing Activities, net	-	-	-	-	-	-	0.03	0.05	0.08	0.06
Net Cash From Financing Activities	7.73	51	8.44	-1.15	39	-1.04	26	9.32	2.64	-4.63
Net Cash From Continuing Financing Activities	7.73	51	8.44	-1.15	39	-1.04	26	9.32	2.64	-4.63
Issuance of Debt	19	105	12	3.00	33	2.00	39	20	16	87
Repayment of Debt	-0.03	-63	-0.03	-0.03	-0.03	-0.03	-0.03	-4.79	-	-78
Payment of Dividends	-11	-11	-12	-12	-12	-12	-13	-13	-13	-13
Other Financing Activities, Net	-0.05	-0.21	-0.10	-1.01	-0.04	-0.05	-0.61	-0.06	-0.29	-0.05
Cash Interest Paid	2.61	3.21	4.06	4.16	2.17	7.34	4.79	5.91	6.23	6.14

This table presents Community Healthcare Trust's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Total Assets	876	945	993
Cash and Due from Banks	11	3.49	4.38
Restricted Cash	0.84	1.14	0.00
Loans and Leases, Net of Allowance	0.00	0.00	0.00
Premises and Equipment, Net	778	849	903
Other Assets	87	91	85
Total Liabilities & Shareholders' Equity	876	945	993
Total Liabilities	380	432	517
Other Short-Term Payables	11	12	14
Long-Term Debt	353	403	486
Other Long-Term Liabilities	15	17	16
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	497	513	476
Total Preferred & Common Equity	497	513	476
Preferred Stock	0.00	0.00	0.00
Total Common Equity	497	513	476
Common Stock	625	688	705
Retained Earnings	-151	-192	-246
Accumulated Other Comprehensive Income / (Loss)	23	16	18

This table presents Community Healthcare Trust's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	812	886	900	955	983	983	982
Cash and Due from Banks	2.66	3.67	2.63	3.89	3.81	0.73	2.84
Restricted Cash	0.68	0.96	1.05	1.05	1.14	0.00	0.00
Loans and Leases, Net of Allowance	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Premises and Equipment, Net	730	797	805	852	880	899	903
Other Assets	79	85	92	98	98	84	76
Total Liabilities & Shareholders' Equity	812	886	900	955	983	983	982
Total Liabilities	333	392	395	433	471	485	505
Other Short-Term Payables	8.14	10	11	15	12	12	14
Long-Term Debt	311	365	368	401	442	458	474
Other Long-Term Liabilities	15	16	16	16	17	16	16
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	478	495	505	522	512	498	477
Total Preferred & Common Equity	478	495	505	522	512	498	477
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	478	495	505	522	512	498	477
Common Stock	602	649	657	677	691	700	702
Retained Earnings	-145	-170	-175	-184	-201	-224	-235
Accumulated Other Comprehensive Income / (Loss)	21	16	23	29	21	21	10

This table displays calculated financial ratios and metrics derived from Community Healthcare Trust's official financial filings.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-
Revenue Growth	7.21%	11.64%	-3.40%
EBITDA Growth	2.99%	9.06%	-32.75%
EBIT Growth	-1.61%	-63.64%	-139.66%
NOPAT Growth	-1.80%	-64.97%	-128.87%
Net Income Growth	-2.10%	-64.97%	-141.24%
EPS Growth	-6.90%	-75.31%	-215.00%
Operating Cash Flow Growth	6.98%	1.83%	-4.08%
Free Cash Flow Firm Growth	-58.75%	41.05%	19.25%
Invested Capital Growth	16.77%	7.85%	4.95%
Revenue Q/Q Growth	1.69%	2.41%	-12.70%
EBITDA Q/Q Growth	-0.31%	1.86%	-25.01%
EBIT Q/Q Growth	-2.99%	-9.01%	-113.96%
NOPAT Q/Q Growth	9.37%	24.64%	-605.32%
Net Income Q/Q Growth	-3.82%	-8.00%	-613.23%
EPS Q/Q Growth	-6.90%	-4.76%	-130.00%
Operating Cash Flow Q/Q Growth	0.69%	-1.79%	2.39%
Free Cash Flow Firm Q/Q Growth	-100.50%	53.93%	-71.98%
Invested Capital Q/Q Growth	7.67%	-0.76%	1.16%
Profitability Metrics	-	-	-
EBITDA Margin	64.34%	62.86%	43.76%
EBIT Margin	25.69%	8.37%	-3.43%
Profit (Net Income) Margin	25.64%	8.05%	-3.43%
Tax Burden Percent	99.81%	96.18%	100.00%
Interest Burden Percent	100.00%	100.00%	100.00%
Effective Tax Rate	0.19%	3.82%	0.00%
Return on Invested Capital (ROIC)	2.79%	0.87%	-0.24%
ROIC Less NNEP Spread (ROIC-NNEP)	2.79%	0.87%	-0.45%
Return on Net Nonoperating Assets (RNNOA)	1.80%	0.65%	-0.41%
Return on Equity (ROE)	4.59%	1.53%	-0.64%
Cash Return on Invested Capital (CROIC)	-12.68%	-6.68%	-5.07%
Operating Return on Assets (OROA)	2.71%	0.88%	-0.33%
Return on Assets (ROA)	2.70%	0.85%	-0.33%
Return on Common Equity (ROCE)	4.59%	1.53%	-0.64%
Return on Equity Simple (ROE_SIMPLE)	4.43%	1.50%	-0.67%
Net Operating Profit after Tax (NOPAT)	22	7.71	-2.23
NOPAT Margin	25.64%	8.05%	-2.40%
Net Nonoperating Expense Percent (NNEP)	0.00%	0.00%	0.21%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	74.31%	91.63%	91.56%
Earnings before Interest and Taxes (EBIT)	22	8.02	-3.18
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	55	60	41
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	1.59	1.30	1.14
Price to Tangible Book Value (P/TBV)	1.59	1.30	1.14
Price to Revenue (P/Rev)	9.18	6.96	5.86
Price to Earnings (P/E)	35.82	86.48	0.00
Dividend Yield	5.66%	7.38%	9.60%
Earnings Yield	2.79%	1.16%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.33	1.16	1.06
Enterprise Value to Revenue (EV/Rev)	13.15	11.12	11.06
Enterprise Value to EBITDA (EV/EBITDA)	20.44	17.69	25.27
Enterprise Value to EBIT (EV/EBIT)	51.20	132.88	0.00
Enterprise Value to NOPAT (EV/NOPAT)	51.30	138.15	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	18.74	17.36	17.39
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.71	0.79	1.02
Long-Term Debt to Equity	0.71	0.79	1.02
Financial Leverage	0.65	0.75	0.90
Leverage Ratio	1.70	1.80	1.96
Compound Leverage Factor	1.70	1.80	1.96
Debt to Total Capital	41.54%	44.00%	50.52%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	41.54%	44.00%	50.52%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	58.46%	56.00%	49.48%
Debt to EBITDA	6.39	6.69	11.99
Net Debt to EBITDA	6.17	6.62	11.88
Long-Term Debt to EBITDA	6.39	6.69	11.99
Debt to NOPAT	16.03	52.28	-218.24
Net Debt to NOPAT	15.48	51.68	-216.27
Long-Term Debt to NOPAT	16.03	52.28	-218.24
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-100	-59	-48
Operating Cash Flow to CapEx	580.96%	323.39%	238.93%
Free Cash Flow to Firm to Interest Expense	-8.43	-3.32	-2.01
Operating Cash Flow to Interest Expense	5.08	3.45	2.48
Operating Cash Flow Less CapEx to Interest Expense	4.20	2.38	1.44
Efficiency Ratios	-	-	-
Asset Turnover	0.11	0.11	0.10
Fixed Asset Turnover	0.12	0.12	0.11
Capital & Investment Metrics	-	-	-
Invested Capital	850	917	962
Invested Capital Turnover	0.11	0.11	0.10
Increase / (Decrease) in Invested Capital	122	67	45
Enterprise Value (EV)	1,130	1,066	1,024
Market Capitalization	789	667	543
Book Value per Share	$19.64	$18.83	$16.85
Tangible Book Value per Share	$19.64	$18.83	$16.85
Total Capital	850	917	962
Total Debt	353	403	486
Total Long-Term Debt	353	403	486
Net Debt	341	399	482
Capital Expenditures (CapEx)	10	19	25
Net Nonoperating Expense (NNE)	0.00	0.00	0.95
Net Nonoperating Obligations (NNO)	353	403	486
Total Depreciation and Amortization (D&A)	33	52	44
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$0.81	$0.20	($0.23)
Adjusted Weighted Average Basic Shares Outstanding	23.63M	25.20M	26.53M
Adjusted Diluted Earnings per Share	$0.81	$0.20	($0.23)
Adjusted Weighted Average Diluted Shares Outstanding	23.63M	25.20M	26.53M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	26.02M	27.68M	28.34M
Normalized Net Operating Profit after Tax (NOPAT)	22	7.81	-2.14
Normalized NOPAT Margin	25.64%	8.15%	-2.31%
Pre Tax Income Margin	25.69%	8.37%	-3.43%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	1.86	0.45	-0.13
NOPAT to Interest Expense	1.85	0.43	-0.09
EBIT Less CapEx to Interest Expense	0.98	-0.62	-1.17
NOPAT Less CapEx to Interest Expense	0.98	-0.63	-1.13
Payout Ratios	-	-	-
Dividend Payout Ratio	202.03%	623.01%	-1,625.21%
Augmented Payout Ratio	202.03%	623.01%	-1,625.21%

This table displays calculated financial ratios and metrics derived from Community Healthcare Trust's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	6.44%	6.98%	11.28%	14.38%	10.61%	10.33%	4.58%	13.94%	23.85%	-55.80%
EBITDA Growth	3.67%	-1.22%	3.88%	15.92%	8.40%	7.96%	-0.36%	-59.49%	27.22%	-95.40%
EBIT Growth	5.46%	-11.45%	-225.06%	18.34%	-33.00%	-15.10%	153.22%	-167.01%	109.62%	-332.97%
NOPAT Growth	-30.31%	272.56%	-159.16%	17.45%	-36.65%	69.51%	176.02%	-147.27%	122.51%	-58.86%
Net Income Growth	5.96%	-14.31%	-225.31%	17.78%	-38.45%	-12.81%	152.95%	-258.54%	-49.91%	-59.89%
EPS Growth	5.00%	-25.00%	-252.38%	14.29%	-47.62%	-5.56%	134.38%	-275.00%	-63.64%	-76.47%
Operating Cash Flow Growth	15.85%	2.77%	-11.83%	10.31%	15.41%	-7.26%	-0.43%	0.32%	-21.85%	9.60%
Free Cash Flow Firm Growth	47.30%	-40.95%	-459.26%	-134.76%	-102.95%	47.89%	26.61%	16.77%	85.16%	29.99%
Invested Capital Growth	9.74%	16.77%	16.04%	14.22%	17.01%	7.85%	10.98%	9.38%	2.97%	4.95%
Revenue Q/Q Growth	2.05%	0.44%	6.07%	5.21%	-1.32%	0.18%	0.54%	14.63%	7.27%	-64.25%
EBITDA Q/Q Growth	0.18%	-0.74%	2.85%	13.34%	-6.31%	-1.14%	-6.36%	-53.92%	194.20%	-96.42%
EBIT Q/Q Growth	1.68%	-7.64%	-230.96%	196.22%	-42.43%	17.04%	-21.50%	-221.17%	280.07%	-230.07%
NOPAT Q/Q Growth	1.30%	-53.57%	-283.03%	236.43%	-45.36%	24.23%	-21.50%	-184.82%	357.25%	-77.03%
Net Income Q/Q Growth	1.59%	-7.67%	-232.15%	195.02%	-46.91%	30.78%	-19.75%	-384.50%	116.77%	4.75%
EPS Q/Q Growth	0.00%	-14.29%	-277.78%	175.00%	-54.17%	54.55%	-35.29%	-481.82%	109.52%	0.00%
Operating Cash Flow Q/Q Growth	1.55%	0.38%	-17.60%	31.33%	6.24%	-19.33%	-11.54%	32.32%	-17.24%	13.14%
Free Cash Flow Firm Q/Q Growth	-47.86%	-85.57%	-3.49%	17.33%	-27.83%	52.36%	-46.26%	6.25%	77.21%	-124.77%
Invested Capital Q/Q Growth	3.21%	7.67%	1.15%	1.61%	5.73%	-0.76%	4.09%	0.15%	-0.47%	1.16%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
EBITDA Margin	63.83%	63.08%	61.16%	65.89%	62.55%	61.72%	58.27%	23.43%	64.25%	6.43%
EBIT Margin	26.14%	24.03%	-29.67%	27.14%	15.83%	18.50%	15.10%	-15.96%	26.80%	-97.49%
Profit (Net Income) Margin	26.04%	23.94%	-29.82%	26.93%	14.49%	18.92%	15.10%	-37.48%	5.86%	17.17%
Tax Burden Percent	99.63%	198.86%	100.51%	99.25%	91.53%	102.28%	100.00%	100.00%	100.29%	99.73%
Interest Burden Percent	100.00%	50.09%	100.00%	100.00%	100.00%	100.00%	100.00%	234.79%	21.81%	-17.66%
Effective Tax Rate	0.37%	0.00%	0.00%	0.75%	5.79%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	2.92%	1.31%	-2.29%	3.00%	1.63%	2.01%	1.61%	-1.23%	3.03%	1.70%
ROIC Less NNEP Spread (ROIC-NNEP)	2.92%	2.15%	-2.95%	3.00%	1.60%	2.03%	1.61%	-3.00%	1.60%	1.70%
Return on Net Nonoperating Assets (RNNOA)	1.76%	1.39%	-1.94%	2.02%	1.14%	1.52%	1.30%	-2.47%	1.40%	1.53%
Return on Equity (ROE)	4.68%	2.70%	-4.23%	5.03%	2.77%	3.53%	2.91%	-3.69%	4.44%	3.22%
Cash Return on Invested Capital (CROIC)	-6.62%	-12.68%	-13.97%	-12.29%	-14.95%	-6.68%	-8.38%	-8.78%	-2.96%	-5.07%
Operating Return on Assets (OROA)	2.83%	2.53%	-3.18%	2.94%	1.68%	1.95%	1.57%	-1.70%	2.94%	-9.32%
Return on Assets (ROA)	2.82%	2.52%	-3.19%	2.92%	1.54%	1.99%	1.57%	-3.99%	0.64%	1.64%
Return on Common Equity (ROCE)	4.68%	2.70%	-4.23%	5.03%	2.77%	3.53%	2.91%	-3.69%	4.44%	3.22%
Return on Equity Simple (ROE_SIMPLE)	4.78%	0.00%	1.94%	2.09%	1.61%	0.00%	3.58%	0.26%	-0.09%	0.00%
Net Operating Profit after Tax (NOPAT)	5.67	2.63	-4.82	6.58	3.59	4.47	3.67	-3.11	8.00	1.84
NOPAT Margin	26.04%	12.04%	-20.77%	26.93%	14.91%	18.50%	15.10%	-11.17%	26.80%	17.22%
Net Nonoperating Expense Percent (NNEP)	0.00%	-0.84%	0.66%	0.00%	0.03%	-0.03%	0.00%	1.77%	1.43%	0.00%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	73.86%	75.97%	129.67%	72.86%	84.17%	81.50%	84.90%	76.43%	73.20%	197.49%
Earnings before Interest and Taxes (EBIT)	5.69	5.26	-6.89	6.63	3.82	4.47	3.67	-4.44	8.00	-10
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	14	14	14	16	15	15	14	6.52	19	0.69
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.51	1.59	1.74	1.57	1.40	1.30	1.35	1.27	1.07	1.14
Price to Tangible Book Value (P/TBV)	1.51	1.59	1.74	1.57	1.40	1.30	1.35	1.27	1.07	1.14
Price to Revenue (P/Rev)	8.58	9.18	9.74	8.69	7.80	6.96	7.15	6.30	4.80	5.86
Price to Earnings (P/E)	31.64	35.82	89.79	75.12	87.07	86.48	37.65	451.84	0.00	0.00
Dividend Yield	6.08%	5.66%	5.37%	5.92%	6.53%	7.38%	7.14%	8.00%	10.11%	9.60%
Earnings Yield	3.16%	2.79%	1.11%	1.33%	1.15%	1.16%	2.66%	0.22%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.31	1.33	1.42	1.33	1.22	1.16	1.18	1.14	1.03	1.06
Enterprise Value to Revenue (EV/Rev)	12.22	13.15	13.83	12.69	12.03	11.12	11.66	10.85	9.24	11.06
Enterprise Value to EBITDA (EV/EBITDA)	18.62	20.44	21.87	19.97	19.04	17.69	23.30	21.81	18.14	25.27
Enterprise Value to EBIT (EV/EBIT)	45.38	51.20	126.21	108.31	127.79	132.88	60.53	58.53	43.01	0.00
Enterprise Value to NOPAT (EV/NOPAT)	51.25	51.30	173.27	143.55	182.00	138.15	61.42	672.23	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	17.24	18.74	20.83	19.26	18.02	17.36	18.43	17.74	17.04	17.39
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.65	0.71	0.74	0.73	0.77	0.79	0.86	0.92	0.99	1.02
Long-Term Debt to Equity	0.65	0.71	0.74	0.73	0.77	0.79	0.86	0.92	0.99	1.02
Financial Leverage	0.60	0.65	0.66	0.67	0.71	0.75	0.80	0.82	0.88	0.90
Leverage Ratio	1.66	1.70	1.71	1.72	1.77	1.80	1.86	1.88	1.94	1.96
Compound Leverage Factor	1.66	0.85	1.71	1.72	1.77	1.80	1.86	4.41	0.42	-0.35
Debt to Total Capital	39.38%	41.54%	42.47%	42.15%	43.44%	44.00%	46.37%	47.90%	49.82%	50.52%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	39.38%	41.54%	42.47%	42.15%	43.44%	44.00%	46.37%	47.90%	49.82%	50.52%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	60.62%	58.46%	57.53%	57.85%	56.56%	56.00%	53.63%	52.10%	50.18%	49.48%
Debt to EBITDA	5.61	6.39	6.54	6.35	6.78	6.69	9.12	9.16	8.77	11.99
Net Debt to EBITDA	5.55	6.17	6.46	6.28	6.70	6.62	9.02	9.15	8.71	11.88
Long-Term Debt to EBITDA	5.61	6.39	6.54	6.35	6.78	6.69	9.12	9.16	8.77	11.99
Debt to NOPAT	15.44	16.03	51.85	45.63	64.82	52.28	24.04	282.48	-1,500.53	-218.24
Net Debt to NOPAT	15.27	15.48	51.19	45.17	64.03	51.68	23.77	282.03	-1,491.54	-216.27
Long-Term Debt to NOPAT	15.44	16.03	51.85	45.63	64.82	52.28	24.04	282.48	-1,500.53	-218.24
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-64	-119	-124	-102	-131	-62	-91	-85	-19	-44
Operating Cash Flow to CapEx	503.31%	418.98%	306.86%	445.17%	495.30%	190.05%	247.27%	232.83%	192.69%	303.51%
Free Cash Flow to Firm to Interest Expense	-21.26	-34.48	-30.97	-24.68	-28.15	-12.40	-17.92	0.00	0.00	-2.34
Operating Cash Flow to Interest Expense	5.07	4.45	3.18	4.03	3.82	2.85	2.50	0.00	0.00	0.84
Operating Cash Flow Less CapEx to Interest Expense	4.06	3.39	2.14	3.12	3.05	1.35	1.49	0.00	0.00	0.56
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.11	0.11	0.11	0.11	0.11	0.11	0.10	0.11	0.11	0.10
Fixed Asset Turnover	0.08	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.11
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	789	850	860	873	923	917	954	955	951	962
Invested Capital Turnover	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.10
Increase / (Decrease) in Invested Capital	70	122	119	109	134	67	94	82	27	45
Enterprise Value (EV)	1,032	1,130	1,220	1,158	1,126	1,066	1,130	1,089	980	1,024
Market Capitalization	724	789	860	794	730	667	693	632	509	543
Book Value per Share	$19.06	$19.64	$19.00	$19.21	$19.67	$18.83	$19.46	$17.97	$17.01	$16.85
Tangible Book Value per Share	$19.06	$19.64	$19.00	$19.21	$19.67	$18.83	$19.46	$17.97	$17.01	$16.85
Total Capital	789	850	860	873	923	917	954	955	951	962
Total Debt	311	353	365	368	401	403	442	458	474	486
Total Long-Term Debt	311	353	365	368	401	403	442	458	474	486
Net Debt	307	341	360	364	396	399	437	457	471	482
Capital Expenditures (CapEx)	3.05	3.68	4.14	3.75	3.58	7.52	5.11	7.19	7.19	5.16
Net Nonoperating Expense (NNE)	0.00	-2.60	2.10	0.00	0.10	-0.10	0.00	7.32	6.25	0.01
Net Nonoperating Obligations (NNO)	311	353	365	368	401	403	442	458	474	486
Total Depreciation and Amortization (D&A)	8.21	8.54	21	9.46	11	10	10	11	11	11
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.21	$0.18	($0.32)	$0.24	$0.11	$0.17	$0.11	($0.42)	$0.04	$0.04
Adjusted Weighted Average Basic Shares Outstanding	23.59M	23.63M	24.23M	25.07M	25.51M	25.20M	26.30M	26.48M	26.66M	26.53M
Adjusted Diluted Earnings per Share	$0.21	$0.18	($0.32)	$0.24	$0.11	$0.17	$0.11	($0.42)	$0.04	$0.04
Adjusted Weighted Average Diluted Shares Outstanding	23.59M	23.63M	24.23M	25.07M	25.51M	25.20M	26.30M	26.48M	26.66M	26.53M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	25.30M	26.02M	26.30M	26.56M	27.26M	27.68M	27.70M	28.06M	28.24M	28.34M
Normalized Net Operating Profit after Tax (NOPAT)	5.67	1.84	-4.82	6.58	3.59	3.13	2.57	-3.01	5.60	1.29
Normalized NOPAT Margin	26.04%	8.43%	-20.77%	26.93%	14.91%	12.95%	10.57%	-10.82%	18.76%	12.05%
Pre Tax Income Margin	26.14%	12.04%	-29.67%	27.14%	15.83%	18.50%	15.10%	-37.48%	5.84%	17.22%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.88	1.52	-1.73	1.60	0.82	0.89	0.72	0.00	0.00	-0.56
NOPAT to Interest Expense	1.87	0.76	-1.21	1.59	0.77	0.89	0.72	0.00	0.00	0.10
EBIT Less CapEx to Interest Expense	0.87	0.46	-2.76	0.70	0.05	-0.61	-0.29	0.00	0.00	-0.83
NOPAT Less CapEx to Interest Expense	0.87	-0.30	-2.24	0.68	0.00	-0.61	-0.29	0.00	0.00	-0.18
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	192.50%	202.03%	471.76%	435.05%	559.51%	623.01%	268.28%	3,858.67%	-11,430.72%	-1,625.21%
Augmented Payout Ratio	192.50%	202.03%	471.76%	435.05%	559.51%	623.01%	268.28%	3,858.67%	-11,430.72%	-1,625.21%

Frequently Asked Questions About Community Healthcare Trust's Financials

When does Community Healthcare Trust's fiscal year end?

According to the most recent income statement we have on file, Community Healthcare Trust's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Community Healthcare Trust's net income changed over the last 2 years?

Community Healthcare Trust's net income appears to be on a downward trend, with a most recent value of -$3.18 million in 2024, falling from $22.02 million in 2022. The previous period was $7.71 million in 2023. View Community Healthcare Trust's forecast to see where analysts expect Community Healthcare Trust to go next.

How has Community Healthcare Trust revenue changed over the last 2 years?

Over the last 2 years, Community Healthcare Trust's total revenue changed from $85.87 million in 2022 to $92.61 million in 2024, a change of 7.8%.

How much debt does Community Healthcare Trust have?

Community Healthcare Trust's total liabilities were at $516.60 million at the end of 2024, a 19.5% increase from 2023, and a 36.1% increase since 2022.

How much cash does Community Healthcare Trust have?

In the past 2 years, Community Healthcare Trust's cash and equivalents has ranged from $3.49 million in 2023 to $11.23 million in 2022, and is currently $4.38 million as of their latest financial filing in 2024.

How has Community Healthcare Trust's book value per share changed over the last 2 years?

Over the last 2 years, Community Healthcare Trust's book value per share changed from 19.64 in 2022 to 16.85 in 2024, a change of -14.2%.

Related Companies

This page (NYSE:CHCT) was last updated on 5/4/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Community Healthcare Trust (CHCT) Financials

Frequently Asked Questions About Community Healthcare Trust's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Community Healthcare Trust (CHCT) Financials

Annual Income Statements for Community Healthcare Trust

Quarterly Income Statements for Community Healthcare Trust

Annual Cash Flow Statements for Community Healthcare Trust

Quarterly Cash Flow Statements for Community Healthcare Trust

Annual Balance Sheets for Community Healthcare Trust

Quarterly Balance Sheets for Community Healthcare Trust

Annual Metrics and Ratios for Community Healthcare Trust

Quarterly Metrics and Ratios for Community Healthcare Trust

Frequently Asked Questions About Community Healthcare Trust's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools